Eli Lilly CEO Dave Ricks slammed the UK’s strict drug pricing rules, warning that the country risks losing new medicines and investment unless changes are made to its rebate schemeEli Lilly CEO Dave Ricks slammed the UK’s strict drug pricing rules, warning that the country risks losing new medicines and investment unless changes are made to its rebate scheme Latest News [ SOBAN NEWS: International and National ]